|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.610 USD | +2.76% |
|
+3.57% | -89.66% |
| 25/06 | Jaguar Health to Seek European Regulatory Approval for Dog Diarrhea Treatment | MT |
| 11/06 | Jaguar Health Establishes First Site for Canalevia-CA1 Field Study | MT |
EPS & Dividend: Jaguar Health, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3,37,500 | -1,32,750 | -54,270 | -2,685 | -130.7 | -10.11 | -3.125 | -0.4 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 2,75,059.062 | 1,16,999.854 | 9,776.238 | 227.100 | 25.250 | 2.610 | 2.610 | 2.610 |
| Nbr of stocks (in thousands) | 0.31 | 0.41 | 1.34 | 33.8 | 472 | 1,324 | - | - |
| Announcement Date | 31/03/21 | 11/03/22 | 24/03/23 | 01/04/24 | 31/03/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Jaguar Health, Inc.
| 13/08/2025 | Q2 2025 Earnings Release (Projected) |
| 12/11/2025 | Q3 2025 Earnings Release (Projected) |
| 06/04/2026 | Q4 2025 Earnings Release (Projected) |
| 18/05/2026 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| - | - | -0.25x | - | -0.13x | ||
| 0.77% | 0.85% | 36.38x | 26.24x | 12.05x | ||
| 3.37% | 3.46% | 14.87x | 5.05x | 4.14x | ||
| 3.5% | 3.66% | 26.47x | 45.99x | 6.45x | ||
| 2.99% | 3.48% | 16.9x | 9.74x | 6.1x | ||
| 3.84% | 3.93% | 14.1x | 5.31x | 3.46x | ||
| 3.26% | 3.43% | 17.49x | 5.18x | 4.7x | ||
| 2.3% | 2.42% | 21.9x | 4.8x | 4.11x | ||
| 3.98% | 4.18% | 10.36x | 3.68x | 3.36x | ||
| 3.27% | 3.44% | 22.28x | 17.44x | 5.74x | ||
| Average | 3.03% | 3.21% | 18.05x | 13.71x | 5.00x | |
| Weighted average by Cap. | 2.68% | 2.85% | 22.63x | 16.35x | 6.62x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition